Fundraising Fox
CYduct Diagnostics
OTC: CYDXWestport, US · Nevada corporation
Find your way into CYduct Diagnostics
Sign up to see every warm intro you have to CYduct Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CYduct Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CYduct Diagnostics (CYductDX) develops and markets medical devices for breast cancer risk assessment, early detection, and diagnosis through an intraductal approach within the mammary ducts. It serves women and their clinicians, applying genetic and proteomic testing to breast health in the medical device and diagnostics industry.
Founders & leadership
GL
Gatto L DomNamed on SEC filing
DG
Dom GattoFounder & CEO
CM
Claus MadsenNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 2 rounds · 2021–2026
▶$2MraisedJul 2026 · BiotechnologyRule 506(b)
▶$2MraisedJul 2026 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gatto L DomExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Jun 2026
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$100KraisedNov 2021 · 1 investors · BiotechnologyRule 506(b)
▶$100KraisedNov 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dom GattoExecutive Officer, Director
- Claus MadsenExecutive Officer
- Offering amount
- $2M
- Amount sold
- $100K
- Minimum investment
- $25K
- Proceeds to insiders
- $275K
- First sale
- Nov 2021
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does CYduct Diagnostics do?
- CYduct Diagnostics (CYductDX) develops and markets medical devices for breast cancer risk assessment, early detection, and diagnosis through an intraductal approach within the mammary ducts. It serves women and their clinicians, applying genetic and proteomic testing to breast health in the medical device and diagnostics industry.
- How much funding has CYduct Diagnostics raised?
- CYduct Diagnostics has disclosed $2.1M raised across 2 rounds.
- Where is CYduct Diagnostics headquartered?
- CYduct Diagnostics is headquartered in Westport, US.